Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

A single preovulatory administration of ulipristal acetate affects the decidualization process of the human endometrium during the receptive period of the menstrual cycle.

Lira-Albarrán S, Durand M, Barrera D, Vega C, Becerra RG, Díaz L, García-Quiroz J, Rangel C, Larrea F.

Mol Cell Endocrinol. 2018 Nov 15;476:70-78. doi: 10.1016/j.mce.2018.04.010. Epub 2018 Apr 27.

PMID:
29709683
2.

Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial.

Simon JA, Catherino W, Segars JH, Blakesley RE, Chan A, Sniukiene V, Al-Hendy A.

Obstet Gynecol. 2018 Mar;131(3):431-439. doi: 10.1097/AOG.0000000000002462.

PMID:
29420395
3.

UPA effects on endometrium - what is the significance?

Pleş L, Sima RM, Carp D, Florescu C, Dimitriu MCT, Ionescu CA.

Rom J Morphol Embryol. 2018;59(4):1127-1132.

4.

Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial.

Cox J, Malik M, Britten J, Lewis T, Catherino WH.

Reprod Sci. 2018 Feb;25(2):198-206. doi: 10.1177/1933719117728802. Epub 2017 Sep 20.

5.

Rationale and design of ASTEROID 2, a randomized, placebo- and active comparator-controlled study to assess the efficacy and safety of vilaprisan in patients with uterine fibroids.

Seitz C, Bumbuliene Ž, Costa AR, Heikinheimo O, Heweker A, Hudeček R, Jacquemyn Y, Melis GB, Parashar P, Rechberger T, Sánchez AC, van Aken B, Zatik J, Gemzell-Danielsson K.

Contemp Clin Trials. 2017 Apr;55:56-62. doi: 10.1016/j.cct.2017.02.002. Epub 2017 Feb 6.

6.

Pharmacokinetics of levonorgestrel and ulipristal acetate emergency contraception in women with normal and obese body mass index.

Praditpan P, Hamouie A, Basaraba CN, Nandakumar R, Cremers S, Davis AR, Westhoff CL.

Contraception. 2017 May;95(5):464-469. doi: 10.1016/j.contraception.2017.01.004. Epub 2017 Jan 23.

PMID:
28126541
7.

A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30 mg ulipristal acetate.

Jesam C, Cochon L, Salvatierra AM, Williams A, Kapp N, Levy-Gompel D, Brache V.

Contraception. 2016 Apr;93(4):310-316. doi: 10.1016/j.contraception.2015.12.015. Epub 2016 Jan 4.

PMID:
26764121
8.

Long-term medical management of uterine fibroids with ulipristal acetate.

Donnez J, Donnez O, Matule D, Ahrendt HJ, Hudecek R, Zatik J, Kasilovskiene Z, Dumitrascu MC, Fernandez H, Barlow DH, Bouchard P, Fauser BC, Bestel E, Loumaye E.

Fertil Steril. 2016 Jan;105(1):165-173.e4. doi: 10.1016/j.fertnstert.2015.09.032. Epub 2015 Oct 23.

9.

A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception.

Brache V, Cochon L, Duijkers IJ, Levy DP, Kapp N, Monteil C, Abitbol JL, Klipping C.

Hum Reprod. 2015 Dec;30(12):2785-93. doi: 10.1093/humrep/dev241. Epub 2015 Sep 23.

PMID:
26405263
10.

In vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment.

Courtoy GE, Donnez J, Marbaix E, Dolmans MM.

Fertil Steril. 2015 Aug;104(2):426-34.e1. doi: 10.1016/j.fertnstert.2015.04.025. Epub 2015 May 21.

PMID:
26003270
11.

The effects on ovarian activity of ulipristal acetate when 'quickstarting' a combined oral contraceptive pill: a prospective, randomized, double-blind parallel-arm, placebo-controlled study.

Cameron ST, Berger C, Michie L, Klipping C, Gemzell-Danielsson K.

Hum Reprod. 2015 Jul;30(7):1566-72. doi: 10.1093/humrep/dev115. Epub 2015 May 20.

PMID:
25994664
12.

Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids.

Donnez J, Hudecek R, Donnez O, Matule D, Arhendt HJ, Zatik J, Kasilovskiene Z, Dumitrascu MC, Fernandez H, Barlow DH, Bouchard P, Fauser BC, Bestel E, Terrill P, Osterloh I, Loumaye E.

Fertil Steril. 2015 Feb;103(2):519-27.e3. doi: 10.1016/j.fertnstert.2014.10.038. Epub 2014 Dec 24.

13.

First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids.

Luyckx M, Squifflet JL, Jadoul P, Votino R, Dolmans MM, Donnez J.

Fertil Steril. 2014 Nov;102(5):1404-9. doi: 10.1016/j.fertnstert.2014.07.1253. Epub 2014 Sep 17.

PMID:
25241376
14.

A randomized study on pharmacodynamic effects of vaginal rings delivering the progesterone receptor modulator ulipristal acetate: research for a novel estrogen-free, method of contraception.

Huang Y, Jensen JT, Brache V, Cochon L, Williams A, Miranda MJ, Croxatto H, Kumar N, Sussman H, Hoskin E, Plagianos M, Roberts K, Merkatz R, Blithe D, Sitruk-Ware R.

Contraception. 2014 Dec;90(6):565-74. doi: 10.1016/j.contraception.2014.08.006. Epub 2014 Aug 12.

15.

Long-term treatment of uterine fibroids with ulipristal acetate ☆.

Donnez J, Vázquez F, Tomaszewski J, Nouri K, Bouchard P, Fauser BC, Barlow DH, Palacios S, Donnez O, Bestel E, Osterloh I, Loumaye E; PEARL III and PEARL III Extension Study Group.

Fertil Steril. 2014 Jun;101(6):1565-73.e1-18. doi: 10.1016/j.fertnstert.2014.02.008. Epub 2014 Mar 12.

16.

Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.

Barlow DH, Lumsden MA, Fauser BC, Terrill P, Bestel E.

Hum Reprod. 2014 Mar;29(3):480-9. doi: 10.1093/humrep/det467. Epub 2014 Jan 23.

PMID:
24457604
17.

Effects of erythromycin at steady-state concentrations on the pharmacokinetics of ulipristal acetate.

Pohl O, Osterloh I, Gotteland JP.

J Clin Pharm Ther. 2013 Dec;38(6):512-7. doi: 10.1111/jcpt.12098. Epub 2013 Sep 16.

PMID:
24102384
18.

Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens.

Brache V, Cochon L, Deniaud M, Croxatto HB.

Contraception. 2013 Nov;88(5):611-8. doi: 10.1016/j.contraception.2013.05.010. Epub 2013 May 22.

PMID:
23809278
19.

Ulipristal acetate - safety and pharmacokinetics following multiple doses of 10-50 mg per day.

Pohl O, Osterloh I, Gotteland JP.

J Clin Pharm Ther. 2013 Aug;38(4):314-20. doi: 10.1111/jcpt.12065. Epub 2013 Apr 3.

PMID:
23550906
20.

Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate.

Williams AR, Bergeron C, Barlow DH, Ferenczy A.

Int J Gynecol Pathol. 2012 Nov;31(6):556-69. doi: 10.1097/PGP.0b013e318251035b.

PMID:
23018219

Supplemental Content

Loading ...
Support Center